Friday, May 17, 2024 at 12:00 PM
Description
CVM GR
Dates and Times
Start: 5/17/2024 12:00 PM
End: 5/17/2024 1:00 PM
Objectives
Describe pathophysiologic mechanisms of HFpEF that may be effected by beta blockers.
Review current evidence for beta blocker use in HFpEF patients.
Implement a strategy for using beta blockers in HFpEF patients in clinical practice.
Speakers
Location
DHLRI 170
473 W 12th Ave,
COLUMBUS, OH 43210
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Need help with this Grand Round Session?
Please contact the Grand Round coordinator listed below:
Jami Jasper
Department:
Phone: 6146854682
Email: jami.jasper@osumc.edu